Researchers at the University of Texas Medical Branch, Galveston, have developed a new platform that can rapidly test neutralizing antibody activity against severe acute respiratory syndrome ...
COVID-19 has united scientists with a shared mission, sense of collaboration, and urgency. Global lab meetings, prompt sharing of scientific results, and resource repositories will continue to advance ...
PHILADELPHIA, Oct. 14, 2025 /PRNewswire/ -- Integral Molecular, a leader in developing innovative tools for antiviral research, announces the launch of its Ready Reporter Virus™ (RRV) neutralization ...
In a recent study posted to the bioRxiv* pre-print server, researchers in the United States described a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-neutralizing monoclonal antibody ...
Researchers have tested alternative ways to measure COVID-19 antibody levels, resulting in a process that is faster, easier and less expensive to use on a large scale. Their method holds promise for ...
Therefore, we administered a third 30-μg BNT162b2 dose 7.9 to 8.8 months after dose 2 to 11 participants 18 to 55 years of age and to 12 participants 65 to 85 years of age from U.S. sites in the phase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results